Table 3.
Details of distant metastasis patients
| No. | Age (yr) | Gender | Location | CEA (ng/mL) | Histological grade | LNM | DFS | Recurrent site | Prognosis |
| 1 | 62 | Male | Ascending colon | 13.66 | Moderately differentiated | 0/3 | 8 | Liver and spleen | Diseased |
| 2 | 61 | Male | Descending colon | 24.00 | Localized canceration | 0/15 | 23 | Liver | Survived |
| 3 | 68 | Male | Rectum | 15.00 | Moderately differentiated | 1/1 | 10 | Liver | Survived |
| 4 | 63 | Female | Sigmoid colon | 7.91 | Moderately differentiated | 0/10 | 30 | Liver and lung | Diseased |
| 5 | 80 | Male | Rectum | 5.20 | Localized canceration | 0/2 | 11 | Liver | Survived |
CEA: Carcinoembryonic antibody; LNM: Lymph node metastasis; DFS: Disease-free survival.